An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)
Exploratory, Prospective, Three-arm, Interventional, Comparative, Randomized, Double-blind, Placebo-controlled, Safety, Efficacy and In-use Tolerability Study of Hair Growth Product(s) in Patients With Mild to Moderate Androgenic Alopecia: (Grade I to III)
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- NovoBliss Research Pvt Ltd
- Participants (registry)
- 108
- Start
- June 2024
- Primary completion
- June 2025
- Study completion
- June 2025
- Last registry update
- September 2025
- Countries
- India
Conditions studied: Androgenic Alopecia
Interventions: SesZen-Bio Serum, Minoxidil hair serum (1%), Placebo, Liposomal Form of SesZenBio, Minoxidil Hair Serum (5%), SesZen-Bio Serum + SesZen-Bio 350 mg extract
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.